SEC Form 4 · accession 0001127602-15-012662
PALL CORP · PLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yves Baratelli
Officer — Group VP, Pres. Life Sciences
Period of report
Mar 25, 2015
Accepted (ET)
Mar 26, 2015 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000075829
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 25, 2015 | M | 15,532 | $59.75 | A | 48,405 | D | |
| Common StockF1 | Mar 25, 2015 | S | 15,532 | $101.17 | D | 32,873 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3,F2 | $59.75 | Mar 25, 2015 | M | 15,532 | D | Jan 18, 2012 | Jan 18, 2019 | Common Stock | 15,532 | 5,178 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $101.23 - $101.98. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, Pall Corporation or a shareholder of Pall Corporation full information regarding the numbers of shares and prices at which the transaction was affected.
- F2Date shown is grant date. These options vest ratably over four years commencing on the first anniversary of the grant date, provided the Reporting Person satisfies certain service conditions.
- F3Only represents the derivative securities in this class.